Source: DGNews | Posted 8 years ago
FDA Approves Flexible Administration Schedule For Lantus (Insulin Glargine [rDNA Origin] Injection)
Tags:
BRIDGEWATER, NJ -- May 8, 2003 -- Aventis today announced that its basal insulin, Lantus



Comments